386 related articles for article (PubMed ID: 28490538)
1. Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance.
Levesque C; Nelson PS
Cold Spring Harb Perspect Med; 2018 Aug; 8(8):. PubMed ID: 28490538
[TBL] [Abstract][Full Text] [Related]
2. Stromal hedgehog signaling maintains smooth muscle and hampers micro-invasive prostate cancer.
Yang Z; Peng YC; Gopalan A; Gao D; Chen Y; Joyner AL
Dis Model Mech; 2017 Jan; 10(1):39-52. PubMed ID: 27935821
[TBL] [Abstract][Full Text] [Related]
3. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
4. The reactive stroma microenvironment and prostate cancer progression.
Barron DA; Rowley DR
Endocr Relat Cancer; 2012 Dec; 19(6):R187-204. PubMed ID: 22930558
[TBL] [Abstract][Full Text] [Related]
5. Extracellular Hsp90 mediates an NF-κB dependent inflammatory stromal program: implications for the prostate tumor microenvironment.
Bohonowych JE; Hance MW; Nolan KD; Defee M; Parsons CH; Isaacs JS
Prostate; 2014 Apr; 74(4):395-407. PubMed ID: 24338924
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated stromal cells as key contributors to the tumor microenvironment.
Bussard KM; Mutkus L; Stumpf K; Gomez-Manzano C; Marini FC
Breast Cancer Res; 2016 Aug; 18(1):84. PubMed ID: 27515302
[TBL] [Abstract][Full Text] [Related]
7. Prostate stromal cells express the progesterone receptor to control cancer cell mobility.
Yu Y; Lee JS; Xie N; Li E; Hurtado-Coll A; Fazli L; Cox M; Plymate S; Gleave M; Dong X
PLoS One; 2014; 9(3):e92714. PubMed ID: 24664419
[TBL] [Abstract][Full Text] [Related]
8. Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.
Leach DA; Need EF; Toivanen R; Trotta AP; Palethorpe HM; Tamblyn DJ; Kopsaftis T; England GM; Smith E; Drew PA; Pinnock CB; Lee P; Holst J; Risbridger GP; Chopra S; DeFranco DB; Taylor RA; Buchanan G
Oncotarget; 2015 Jun; 6(18):16135-50. PubMed ID: 25965833
[TBL] [Abstract][Full Text] [Related]
9. Identification of SFRP1 as a candidate mediator of stromal-to-epithelial signaling in prostate cancer.
Joesting MS; Perrin S; Elenbaas B; Fawell SE; Rubin JS; Franco OE; Hayward SW; Cunha GR; Marker PC
Cancer Res; 2005 Nov; 65(22):10423-30. PubMed ID: 16288033
[TBL] [Abstract][Full Text] [Related]
10. "Stromal cells in prostate cancer pathobiology: friends or foes?".
Pederzoli F; Raffo M; Pakula H; Ravera F; Nuzzo PV; Loda M
Br J Cancer; 2023 Apr; 128(6):930-939. PubMed ID: 36482187
[TBL] [Abstract][Full Text] [Related]
11. Genes upregulated in prostate cancer reactive stroma promote prostate cancer progression in vivo.
Dakhova O; Rowley D; Ittmann M
Clin Cancer Res; 2014 Jan; 20(1):100-9. PubMed ID: 24150235
[TBL] [Abstract][Full Text] [Related]
12. Interaction between prostate cancer cells and prostate fibroblasts promotes accumulation and proteolytic processing of basement membrane proteins.
Ojalill M; Virtanen N; Rappu P; Siljamäki E; Taimen P; Heino J
Prostate; 2020 Jun; 80(9):715-726. PubMed ID: 32364250
[TBL] [Abstract][Full Text] [Related]
13. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
[TBL] [Abstract][Full Text] [Related]
14. SOCS1 inhibits migration and invasion of prostate cancer cells, attenuates tumor growth and modulates the tumor stroma.
Villalobos-Hernandez A; Bobbala D; Kandhi R; Khan MG; Mayhue M; Dubois CM; Ferbeyre G; Saucier C; Ramanathan S; Ilangumaran S
Prostate Cancer Prostatic Dis; 2017 Mar; 20(1):36-47. PubMed ID: 27779203
[TBL] [Abstract][Full Text] [Related]
15. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling.
Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR
Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536
[TBL] [Abstract][Full Text] [Related]
16. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts.
Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N
Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625
[TBL] [Abstract][Full Text] [Related]
17. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis.
Yang F; Tuxhorn JA; Ressler SJ; McAlhany SJ; Dang TD; Rowley DR
Cancer Res; 2005 Oct; 65(19):8887-95. PubMed ID: 16204060
[TBL] [Abstract][Full Text] [Related]
18. Asporin is a stromally expressed marker associated with prostate cancer progression.
Rochette A; Boufaied N; Scarlata E; Hamel L; Brimo F; Whitaker HC; Ramos-Montoya A; Neal DE; Dragomir A; Aprikian A; Chevalier S; Thomson AA
Br J Cancer; 2017 Mar; 116(6):775-784. PubMed ID: 28152543
[TBL] [Abstract][Full Text] [Related]
19. Gene promoter methylation in prostate tumor-associated stromal cells.
Hanson JA; Gillespie JW; Grover A; Tangrea MA; Chuaqui RF; Emmert-Buck MR; Tangrea JA; Libutti SK; Linehan WM; Woodson KG
J Natl Cancer Inst; 2006 Feb; 98(4):255-61. PubMed ID: 16478744
[TBL] [Abstract][Full Text] [Related]
20. Key participants of the tumor microenvironment of the prostate: an approach of the structural dynamic of cellular elements and extracellular matrix components during epithelial-stromal transition.
Gonçalves BF; Campos SG; Costa CF; Scarano WR; Góes RM; Taboga SR
Acta Histochem; 2015 Jan; 117(1):4-13. PubMed ID: 25466989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]